Priority Date: 21.10.11 (US 201161549844P)

RECOMBINANT NON-PATHOGENIC MAREK'S DISEASE VIRUS CONSTRUCTS ENCODING INFECTIOUS LARYNGOTRACHEITIS VIRUS AND NEWCASTLE DISEASE VIRUS ANTIGENS

  • Application ID: EP12775246
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
2 offices
Technology Company
no operation time available
7 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). MSD Animal Health and Merck Sharp & Dohme Ltd. are specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 182 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 21.10.2011 - Priority Date (US 201161549844P)
  • 25.04.2013 - Publication A1 (WO2013057236)
  • 27.08.2014 - Publication A1 (EP2768964)